{
  "run_id": "RUN_20260204_132700_1fed028ce5fb",
  "timestamp": "2026-02-04T15:03:34.763444",
  "document": "03_Marketing_WINREVAIR EU Expansion.pdf",
  "document_path": "/Users/frederictetard/Projects/ese/gold_data/PAPERS/03_Marketing_WINREVAIR EU Expansion.pdf",
  "pipeline_version": "0.8",
  "total_detected": 2,
  "unique_identifiers": 1,
  "validation_summary": {
    "total_validated": 1,
    "valid_count": 1,
    "invalid_count": 0,
    "error_count": 0
  },
  "citations": [
    {
      "pmid": null,
      "pmcid": null,
      "doi": null,
      "nct": "NCT04896008",
      "url": null,
      "citation_text": "Health Organization About ZENITH The ZENITH study (NCT04896008) was a global, double-blind, placebo-controlled, multicenter, parallel-group clinical",
      "citation_number": null,
      "page": 1,
      "confidence": 0.95,
      "validation": {
        "is_valid": true,
        "resolved_url": "https://clinicaltrials.gov/study/NCT04896008",
        "title": "A Study of Sotatercept in Participants With PAH WHO FC III or FC IV at High Risk of Mortality (MK-7962-006/ZENITH)",
        "status": "COMPLETED",
        "error": null
      }
    },
    {
      "pmid": null,
      "pmcid": null,
      "doi": null,
      "nct": null,
      "url": "http://www.merck.com/product/usa/pi_circulars/w/winrevair/winrevair_pi.pdf",
      "citation_text": "Prescribing Information for WINREVAIR (sotatercept-csrk) at http://www.merck.com/product/usa/pi_circulars/w/winrevair/winrevair_pi.pdf, Patient Information for WINREVAIR at http://www.merck.com/produc",
      "citation_number": null,
      "page": 1,
      "confidence": 0.8,
      "validation": null
    }
  ]
}